LifeMD Inc. (LFMD)
NASDAQ: LFMDHealth CareMedical/Nursing ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
LFMD stock chart
Technical analysisKey statistics
All statistics- Market cap
- $69.84M
- Forward P/E
- 9.32
- EPS (TTM)
- -$0.52
- Dividend yield
- None
- 52-week range
- 1.38 – 5.38
- Day range
- 1.38 – 1.58
- Volume / Avg
- 1.58M / 929.40K
- Beta
- —
- Shares outstanding
- 48.33M
52-week range
LFMD stock today
Shares of LifeMD (LFMD) finished lower on Nov 20 at $1.45, a drop of 9.40% or $0.15 per share, versus the S&P 500's 3.70% decline. Shares are 73.1% below their 52-week high of $5.38, set on May 6, 2026 and 4.7% above the 52-week low of $1.38, near the bottom of the past year's range. LFMD is down 57.6% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 62.5%.
LifeMD has posted a net loss over the last twelve months (EPS of -$0.52), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About LifeMD
Company profileLifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss.
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- CEO
- Mr. Justin Schreiber
- Headquarters
- New York, NY
- Employees
- 347
- Website
- lifemd.com
Financial highlights
Full financialsIn fiscal 2025, LifeMD generated $194.1 million in revenue, up 25.3% from fiscal 2024, its 8th consecutive year of revenue growth. Net income was $14.4 million, for a net margin of 7.4% versus a median of -38.3% in the prior 5 years. Gross margin was 85.7% (down from 86.2%) and operating margin -4.0%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $194.06M | $154.82M | $152.55M | $119.03M | $92.88M |
| Growth | +25.34% | +1.49% | +28.15% | +28.16% | +149.04% |
| Net income | $14.35M | $-21.41M | $-20.60M | $-45.54M | $-60.90M |
| EPS (diluted) | $0.25 | $-0.60 | $-0.70 | $-1.57 | $-2.29 |
Analyst forecast
ForecastConsensus (8 analysts)
strong_buy
Avg. price target
$8.13+462.63%
- Strong buy 0
- Buy 8
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 12, 2026
- EPS actual vs est.
- $-0.10 vs $-0.14
- Surprise
- +28.57%
LFMD news
All LFMD news- LifeMD: 3 Key Takeaways for Long-Term InvestorsNasdaq
- LifeMD (LFMD) Q3 2026 Earnings Call TranscriptNasdaq
- LifeMD Reports Third Quarter 2026 ResultsGlobeNewswire
- LifeMD Reschedules Third Quarter 2026 Earnings Release and Conference Call to November 12, 2026GlobeNewswire
- LifeMD expands access to Lilly’s self-pay GLP-1 medicines, enabling option to dispense and ship directly to patients nationwideGlobeNewswire
- LifeMD to Report Third Quarter 2026 Financial Results on November 9GlobeNewswire
LifeMD peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NAKANakamoto Inc. | 3.44 | -15.89% | $63.11M | vs LFMD |
| EUDAEUDA Health Holdings Limited Class A | 15.96 | -7.69% | $47.79M | vs LFMD |
| AIRSAirSculpt Technologies Inc. | 0.5907 | -9.72% | $43.67M | vs LFMD |
| ALPSALPS Group Inc | 1.15 | -3.36% | $36.43M | vs LFMD |
| DCGODocGo Inc. | 0.175 | +1.98% | $17.32M | vs LFMD |
| CCMConcord Medical Services Holdings Limited ADR | 3.55 | -1.11% | $15.41M | vs LFMD |
| BMGLBasel Medical Group Ltd | 0.3832 | +20.01% | $5.20M | vs LFMD |
| ATPCAgape ATP Corporation | 1.16 | -15.94% | $1.16M | vs LFMD |
Indexes, lists and sector
LifeMD stock FAQ
What is LifeMD's stock price today?
LFMD last traded at $1.45 as of Nov 20, 4:00 PM EST, down 9.40% on the day. Prices are delayed at least 15 minutes.
Does LifeMD pay a dividend?
No. LifeMD does not currently pay a regular cash dividend.
Who is LifeMD's CEO?
Mr. Justin Schreiber is the chief executive officer of LifeMD Inc., which has about 347 employees.
Has LFMD ever split its stock?
Yes. The most recent LFMD stock split was a 1-for-5 split on Oct 14, 2020.
What is the LFMD 52-week high?
The 52-week high for LFMD is $5.38 and the 52-week low is $1.38. The stock is currently 73.1% below its high.